Tissium
FranceWho owns Tissium?
Tissium is a French MedTech company, currently owned by ISALT since 2023 and 7 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Crédit Mutuel Equity, Crédit Mutuel Innovation, Ibionext, Karista, Sofinnova Partners, Omnes Capital, Cathay Capital and ISALT since 2013.
- ·8 distinct PE sponsors across ownership cycles.
Ownership history
8 ownership periods · co-invest detected
More from Fonds Stratégique des Transitions (FST)
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Tissium?
Tissium is currently owned by ISALT, Cathay Capital and 6 others, through Fonds Stratégique des Transitions (FST), since 2023.
When did ISALT and 7 others acquire Tissium?
ISALT and 7 others acquired Tissium in 2023.
Who has owned Tissium over time?
Tissium has been through 8 private-equity ownership periods: Crédit Mutuel Equity · via Crédit Mutuel Equity · since 2013; Crédit Mutuel Innovation · via Crédit Mutuel Innovation Evergreen Capital · since 2013; Ibionext · via iBionext Growth Fund · since 2013; Karista · via CapDecisif 3 · since 2014; Sofinnova Partners · via Sofinnova Capital IX · since 2018; Omnes Capital · via Omnes Real Tech 1 · since 2019; Cathay Capital · via Cathay Health · since 2021; ISALT · via Fonds Stratégique des Transitions (FST) · since 2023.